Skip to main content
Equibles
RMD logo

RMD · Resmed Inc

Track RMD — free

Use RMD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$231.36 -8.74 (-3.64%) At close · Sep 1
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$34.67B
Shares
144.25M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$240.10 Open$237.97 Day$236.16–241.71 52W close$182.82–283.28 Avg vol 30d1.4M Short int12.8M · 8.9% float · 7.4d Short vol77% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-K · Aug 13

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 9 wks
FQ1-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-K
filed Aug 13, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 16.3 · calm Equity put/call 0.67
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +5%
above
Price vs 50-day avg +13%
above
RSI (14) 69
neutral
MACD trend Positive
52-week position 57%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −3%
trailing
YTD return 0%
this year
Relative strength −16%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $212 › 200d $229 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +91 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.87% of float · ▼ -18.4% MoM · 7.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
891 holders — mid 3-yr range
Squeeze score 74
high risk · 0–100
Fundamentals
Excellent
Revenue growth +13%
Y/Y
Gross margin 117%
contracting
EPS growth +10%
Y/Y
Free cash flow $1.6B
Valuation P/E 23
below peers
Balance sheet $809.9M
net cash
Quant / Vol
risk profile
Moderate
Volatility 28%
annualized · 1-yr
Max drawdown −35%
past year
ATR 2.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+5% Bullish
Price vs 50-day avg
+13% Bullish
RSI (14)
69 Neutral
MACD trend
Positive Bullish
52-week position
57% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $212 › 200d $229 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +91 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.87% of float · ▼ -18.4% MoM · 7.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
891 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $183 Now $240 · 57% Range high $283
vs 200-day avg +5% vs 50-day avg +13%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
RMD
Resmed Inc
this stock
$34.67B -0.3% +13.4% 23.0 8.9%
ISRG
Intuitive Surgical Inc
 $130.45B -33.5% +20.5% 42.4 2.0%
BDX
Becton Dickinson & Co
 $51.24B — +8.2% — 3.4%
MDLN
Medline Inc.
 $46.38B -16.6% +11.5% — 2.8%
ALC
Alcon Inc
 $34.83B -9.0% +10.5% — 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
891
% held
70.0%
Net QoQ
+2.5M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
768
View
Short & Settlement
Short Interest Falling
Shares short
12.8M
Days to cover
7.4d
Change
-2.9M sh
View
Short Volume
Short vol %
77%
As of
Sep 1, 2026
Short Total
View
Fails to Deliver
FTD shares
22
Value
$4.9K
As of
Aug 12, 2026
View
Off-Exchange
Off-exchange %
43.1%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 27, 2026
View
Financials
Financials
Revenue (FY)
$5.7B
Net income (FY)
$1.5B
EPS diluted
$10.43
View
Buybacks
Authorized
shares 20.0M
Remaining
shares 7.9M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 1, 2026
This year
11
View
Proposed Sales
Value
$1.0M
Shares
5.0K
Filed
Aug 7, 2026
View
Earnings & Events
Earnings Calls Upcoming
Next call
Sep 15, 2026
Last call
Aug 6, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
RMD +3.3% +11.6% -2.8% +13.8% -0.3%
SPY +0.5% +1.2% +13.3% +2.7% +12.5%
vs SPY +2.8% +10.3% -16.1% +11.1% -12.8%

Capital returns

Latest dividend
$0.66 / share · ex Aug 20, 2026
Raised 10%
Paid (TTM)
$2.46 / share · 4 payouts
Dividend yield (TTM, derived)
1.02%
Buyback program · as of Jun 30, 2026
Authorized
shares 20.00M
Spent (derived)
shares 12.10M
Remaining
shares 7.90M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 943819 CUSIP 761152107 13F (30d) 596 filings 575 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)